Find uplifting stories about heroes, innovations, and solutions
289 results for "obesity"
France just became the first EU country to cover breakthrough obesity medications for severely obese patients, helping one million people access treatments that previously cost €300 per month. The bold public health move recognizes obesity as a serious medical condition deserving national support.
The American Medical Association just adopted sweeping policies to make weight loss medications and comprehensive obesity care more affordable for millions of Americans. The move addresses one of healthcare's biggest cost barriers while recognizing obesity as a chronic disease requiring long-term support.
The UAE's new obesity intervention strategy could help 1.2 million adults overcome obesity while adding $51 billion to the national economy. The ambitious health initiative proves that investing in public wellness creates powerful economic ripple effects.
A groundbreaking UAE report reveals that helping 1.2 million adults overcome obesity could boost the nation's GDP by $51 billion while saving $1.5 billion in healthcare costs. The findings show that treating obesity isn't just good medicine—it's smart economics.
Scientists at Yale discovered that obesity triggers pancreatic cells to produce a hormone that drives cancer development, opening the door to early detection through simple blood tests. The breakthrough challenges decades of scientific assumptions about how obesity leads to one of the deadliest cancers.
A drug that flopped in Alzheimer's trials just helped obese mice lose 20% of their body weight without eating less or exercising more. Johns Hopkins researchers are now testing whether this accidental discovery could help millions of people struggling with severe obesity.
After 25 years of taking affordable blood pressure and cholesterol medications, older adults with obesity now have heart health markers as good as their peers with normal weight. The shift shows how $100-a-year generic drugs are quietly changing what obesity means for cardiovascular risk.
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
A breakthrough obesity treatment helped patients lose nearly 30% of their body weight—results previously only achievable through surgery. The experimental drug could transform how millions manage obesity while Medicare makes these treatments more affordable.
Scientists discovered a molecule from python blood that helps obese mice lose 9% of their weight in 28 days, without the stomach problems linked to current obesity drugs. The breakthrough could lead to a new generation of weight-loss treatments inspired by how pythons digest massive meals.
After decades of climbing obesity rates worldwide, some wealthy countries are seeing progress. New research shows rates leveling off in most high-income nations and possibly declining in France, Italy, and Portugal.
Doctors are discovering why weight-loss drugs work brilliantly for some people but fail for others. The answer could revolutionize how we treat obesity within just a few years.
A groundbreaking Louisiana law requires insurance to cover weight loss surgery, potentially helping thousands get the medical procedures they need. The 2024 legislation addresses a troubling gap where severely obese patients are being denied necessary operations.
Scientists discovered that severe obesity weakens heart muscle cells in a common form of heart failure, but losing weight can reverse the damage. The breakthrough could help 6.6 million Americans living with heart failure.
Science is finally debunking the most harmful myths about obesity, replacing decades of blame with evidence-based treatment. Over one billion people worldwide now have access to better information and medical care for what experts classify as a chronic disease.
Greece transformed from having Europe's worst childhood obesity rates to becoming a WHO model country in just a few years. The nationwide program reached 75% of families and helped eight in 10 overweight children achieve healthy weight.
%2Ffile%2Fattachments%2F2992%2F13971407_975900.jpg)
Starting mid-June, France becomes the first EU nation to reimburse life-changing weight-loss medications for severely obese patients. Up to one million people could access treatments that currently cost €300 monthly out of pocket.
Eli Lilly has granted one person extraordinary access to its next-generation obesity treatment through an FDA compassionate use program. The decision marks a rare exception that could offer hope to patients waiting for breakthrough treatments.
Popular weight loss medications like GLP-1 drugs might do more than help people shed pounds. New research suggests they could also improve testosterone levels and sperm quality in men with obesity.
Millions of Americans struggling with obesity now have a new option: the FDA just approved Foundayo, the first oral tablet in a groundbreaking class of weight-loss medications. This pill could transform treatment by offering an easier alternative to weekly injections.
Showing 20 of 289